Hostname: page-component-77c89778f8-rkxrd Total loading time: 0 Render date: 2024-07-17T10:34:32.260Z Has data issue: false hasContentIssue false
  • English
  • Français

Current Epidemiology of Multidrug-Resistant Gram-Negative Bacilli in the United States

Published online by Cambridge University Press:  02 January 2015

Alexander J. Kallen  and
Arjun Srinivasan
Alexander J. Kallen*
Affiliation:
Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia
Arjun Srinivasan
Affiliation:
Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia
*
1600 Clifton Road NE, MS A-35, Atlanta, GA 30333 (AKallen@cdc.gov)
Get access Rights & Permissions [Opens in a new window]

Abstract

Gram-negative bacilli are an important cause of infection in healthcare and community settings. Antimicrobial resistance, including resistance to multiple antimicrobial classes, is an ongoing problem among gram-negative bacilli. This synopsis reviews the incidence of multidrug resistance among gram-negative bacilli in the United States and describes emerging issues in their epidemiology.

Type
Supplement Article
Information
Infection Control & Hospital Epidemiology , Volume 31 , Issue S1: Papers from the Fifth Decennial International Conference on Healthcare-Associated Infections , November 2010 , pp. S51 - S54
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Yigit, H, Queenan, AM, Anderson, GJ, et al.Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 2001;45(4):1151–1161.CrossRefGoogle ScholarPubMed
2.Pournaras, S, Protonotariou, E, Voulgari, E, et al.Clonal spread of KPC-2 carbapenemase-producing Klebsiella pneumoniae strains in Greece. J Antimicrob Chemother 2009;64(2):348–352.CrossRefGoogle ScholarPubMed
3.O'Fallon, E, Gautam, S, D'Agata, EMC. Colonization with multidrug-resistant gram-negative bacteria: prolonged duration and frequent co-colonization. Clin Infect Dis 2009;48(10):1375–1381.Google Scholar
4.O'Fallon, E, Pop-Vicas, A, D'Agata, E. The emerging threat of multidrug-resistant gram-negative organisms in long-term care facilities. J Gerontol A Biol Sci Med Sci 2009;64(1):138–141.CrossRefGoogle ScholarPubMed
5.Pop-Vicas, A, Strom, J, Stanley, K, D'Agata, EMC. Multidrug-resistant gram-negative bacteria among patients who require chronic hemodialysis. Clin J Am Soc Nephrol 2008;3(3):752–758.CrossRefGoogle ScholarPubMed
6.Romero, L, Lopez, L, Rodriguez-Bano, J, Ramon Hernandez, J, Martinez-Martinez, L, Pascual, A. Long-term study of the frequency of Escherichia coli and Klebsiella pneumoniae isolates producing extended-spectrum β-lactamases. Clin Microbiol Infect 2005;11(8):625–631.CrossRefGoogle ScholarPubMed
7.Coque, TM, Baquero, F, Canton, R. Increasing prevalence of ESBL-producing Enterobacteriaciae in Europe. Euro Surveill 2008;13(47):19–29.CrossRefGoogle Scholar
8.Lewis, JS, Herrera, M, Wickes, B, Patterson, JE, Jorgensen, JH. First report of the emergence of CTX-M-type extended-spectrum β-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system. Antimicrob Agents Chemother 2007;51(11):4015–4021.Google Scholar
9.Lewis, JS, Herrera, M, Wickes, B, Fulcher, L, McElmeel, L, Jorgensen, JH. Clinical experience with E. coli CTX-M ESBL urinary tract infections in a U.S. healthcare system. In: Program and Abstracts of the 49th Annual Interscience Conference on Antimicrobial Agents and Chemotherapeutics; September 12–15, 2009; San Francisco, California. Abstract K-271.Google Scholar
10.Elemam, A, Rahimian, , Mandell, W. Infection with panresistant Klebsiella pneumonia: a report of 2 cases and a brief review of the literature. Clin Infect Dis 2009;49(2):271–274.Google Scholar